Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.1 (
Mg2+-ATPase
)
1,484
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sarcoplasmic reticulum (SR), Ca2+ plus
Mg2+-ATPase
, and Ca2+-ionophore were obtained from white rabbit skeletal muscles. Methylmercury inhibited the Ca2+ plus
Mg2+-ATPase
and Ca2+-transport but had no effect on the Ca2+-ionophore. Mercuric chloride inhibited all three functions (i.e., ATPase, transport and ionophoric activity). The mechanism of HgCl2 inhibition of the Ca2+-ionophore was by competition with Ca2+ for Ca2+-ionophoric site whereas its inhibition of the enzyme and Ca2+-transport was due to the blockage of essential sulfhydryl (--SH) groups. Ca2+ plus
Mg2+-ATPase
and Ca2+-transport were more sensitive to methylmercury than to HgCl2. Acetylcholine receptor (AChR) was obtained for the electric organ of T. californica. Methylmercury inhibited the
ACh
binding to AChR WITH Ki = 5.7 - 10(-6) M. This effect was not due to mercuric ion alone since mercuric chloride up to 10(-4) M did not affect
ACh
binding to AChR. It is concluded that: the Ca2+ plus
Mg2+-ATPase
and Ca2+-transport contain --SH groups essential for their activity, and that the two functions are tightly coupled; the Ca2+-ionophore contains no --SH groups essential for its activity; CH3HgCl inhibition of Ca2+ plus
Mg2+-ATPase
and Ca2+-transport is partly due to its reactivity with --SH groups in hydrophobic environment; the Ca2+-transport is inhibited by HgCl2 through two processes, one which is the blockage of --SH groups and another which is the inhibition of the Ca2+-ionophoric site; and the inhibition of
ACh
binding to AChR is due to the blockage of --SH groups in hydrophobic environment, which is inaccessible to Hg2+. Our data present for the first time a molecular basis for the myopathy associated with mercurial compounds toxicity.
...
PMID:Differential effects of mercurial compounds on excitable tissues. 12 2
Synaptic vesicles purified on a sucrose-KCl sedimentation gradient were tested for their ability to accumulate [1-14C]acetylcholine ([1-14C]
ACh
) in the absence and in the presence of AH5183 and cetiedil. Kinetic studies of
ACh
transport showed that it was time dependent and saturable as a function of
ACh
concentration, with a KT of 1.2 mM. The protein-modifying agents N-ethylmaleimide and 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole were powerful inhibitors of
ACh
uptake. In agreement with other studies, AH5183 was found to be a potent inhibitor of
ACh
uptake by synaptic vesicles. Inhibition was of the mixed noncompetitive type, and the inhibition constant was 45.2 +/- 3.4 nM. Cetiedil, a drug that resembles
ACh
, was previously shown on intact nerve endings to inhibit the translocation of newly synthesized
ACh
into the synaptic vesicle compartment, and we demonstrate here that cetiedil is indeed an efficient blocker of
ACh
uptake by isolated synaptic vesicles. It acted as a competitive inhibitor, with a Ki of 118.5 +/- 9.5 nM. Neither ATP-dependent calcium uptake nor
Mg2+-ATPase
activity was affected by the drugs, a finding showing their specificity toward the
ACh
uptake process. The binding of L-[3H]AH5183 to intact vesicles was characterized in the absence or the presence of
ACh
or cetiedil. Saturation experiments showed a total binding capacity of approximately 126 pmol/mg of vesicular protein and a dissociation constant of 19.9 +/- 4.1 nM under control conditions.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:AH5183 and cetiedil: two potent inhibitors of acetylcholine uptake into isolated synaptic vesicles from Torpedo marmorata. 252 93
During aerobic incubation at 37 degrees C, active uptake of labeled non-metabolizable alpha-aminoisobutyric acid (AIB) into isolated nodose ganglia (NG) excised from adult rats was accelerated to nearly twice that of the control, by the addition of glia maturation factor (GMF, 5 micrograms/ml) in a dose-dependent manner. A similar but moderate stimulative effect on ganglionic AIB uptake was caused by the addition of acetylcholine (
ACh
, 1 mM) plus eserine (0.1 mM). This effect, however, was not antagonized by nicotinic (hexamethonium, C6, 0.1 mM) or muscarinic (atropine, 0.1 mM) blockers. The GMF-induced amino acid uptake seemed to be inhibited by further addition of
ACh
. On the other hand, ganglionic Ca2+,
Mg2+-ATPase
activity was greatly stimulated by either GMF or
ACh
. These results suggest that the increase in AIB uptake induced by GMF or
ACh
is possibly linked to Ca2+,
Mg2+-ATPase
activity in NG cell membranes.
...
PMID:Stimulative effect of glia maturation factor and acetylcholine on active amino acid uptake and Ca2+,Mg2+-ATPase activity in nodose ganglia excised from adult rats. 294 Nov 10